User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
November 8th, 2021 04:23
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
November 4th, 2021 08:08
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
November 1st, 2021 02:24
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 29th, 2021 09:14
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 27th, 2021 03:04
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 25th, 2021 06:30
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 23rd, 2021 18:14
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 22nd, 2021 13:01
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 21st, 2021 13:43
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 20th, 2021 19:29
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 20th, 2021 05:23
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 19th, 2021 18:43
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 19th, 2021 10:45
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 19th, 2021 04:54
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 19th, 2021 00:46
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 21:59
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 18:57
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 18:13
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:51
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:38
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:30
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:29
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:28
|
User emandity@marian.edu has attached Hyku_Palsave_Placeholder.pdf to Osilodrostat for the treatment of Cushing's disease |
October 18th, 2021 17:28
|